Abstract
Recent reports suggest the presence of osteopenia in a high percentage of patients with Parkinson's disease (PD). These data contrast with previous reports of our group, perhaps due to the different methods used. We studied bone mass in 52 PD patients (28 males, 24 females) and in 80 age- and sex-matched controls (40 males, 40 females) who had no other disease that could affect bone mass. We measured the totally body bone mienral content (TBBMC) and the ultrasound bone velocity (UBV) of transmission in phalanx, and performed metacarpal radiogrammetry with computerized radiography (CCT). We also measured serum levels of total alkaline phosphatase and tartrate-resistant acid phosphatase, which were significantly increased in PD patients compared with controls (P<0.0001). TBBMC was significantly lower in males (P<0.05) and females (P<0.05) with PD with respect to their controls. CCT did not differ significantly between the study groups. UBV was significantly lower in males with PD (P<0.005), but similar in female PD and controls. These data suggest that the changes reported in bone mass in PD patients can depend on the sex and the study methods. We only found severe osteopenia in one male (3.6%) and five females (20.8%) with PD according to z-score. Only in women was no relationship found between TBBMC and severity of PD.
Similar content being viewed by others
References
Turc JD, Pages M, Poulles JM, et al. (1993) Bone changes in Parkinson's disease (Abstract) Neurology 43:A236
Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S (1993) Relationship between osteopenia and clinical characteristics of Parkinson's disease. Mov Disord 8:507–511
Ishizaki F, Harada T, Katayama S, Abe H, Nakamura S (1993) Bone changes in Parkinson's disease. No To Shinkei 45:719–724
Kao CH, Chen CC, Wang SJ, Chia LG, Yeh SH (1994) Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry. Nucl Med Commun 15:173–177
Rico H, Vázquez A, Cabranes JA, et al (1987) Long-term influence of levodopa on bone mass and growth hormone in postmenopausal women with Parkinson's disease. Clin Neuropharmacol 10:87–91
Hughes AJ, Ben-Shlomo SE, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease?—a clinicopathological study. Neurology 42:1142–1146
Fahn S, Elton RL, and members of the UPDRS Development Committee (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson's disease. MacMillan, Florham Park, New Jersey, pp 153–163
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:419–423
Rico H, Revilla M, Villa LF, Hernández ER, Fernández JP (1992) Crush fracture syndrome in senile osteoporosis—a nutritional consequence? J Bone Miner Res 7:317–319
Rico H, Revilla M, Fraile E, Martín FJ, Cárdenas JL, Villa LF (1994) Metacarpal cortical thickness by computed radiography in osteoporosis. Bone 15:303–306
Rico H, Aguado F, Revilla M, Villa LF, Martín FJ (1994) Ultrasound bone velocity and metacarpal radiogrammetry in hemodialized patients. Miner Electrol Metab 20:103–106
Lam KW, Lai L, Yam LT (1978) Tartrate-resistant (band 5) acid phosphatase activity measured by electrophoresis on acrylamide gel. Clin Chem 24:309–312
Rico H, Villa LF (1993) Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling. Calcif Tissue Int 52:149–150
Descos L, Andre C, Beorghia S, Vincent C, Revillard JP (1979) Serum levels of beta-2-microglobulin—a new marker of activity in Crohn's disease. N Eng J Med 302:440
Johnston CC, Melton LJ, Lindsay R, Eddy DM (1989) Clinical indications for bone mass measurements. J Bone Miner Res 4 (suppl 2):1–28
Sartoris DJ, Resnick D (1990) Current and innovate methods for nonivasive bone densitometry. Radiol Clin North Am 28:257–278
Gotfredsen A, Podenphant J, Nilas L, Christiansen C (1989) Discriminative ability of total body bone-mineral measured by dual photon absorptiometry. Scand J Clin Lab Invest 49:125–34.
Meema HE, Meindock H (1992) Advantages of peripheral radiogrammetry over dual-photon absorptiometry of the spine in the assessment of prevalence of osteoporotic vertebral fractures in women. J Bone Miner Res 7:897–903
Wishart JM, Horowitz M, Bochner M, Need AG, Nordin BEC (1993) Relationships between metacarpal morphometry, forearm and vertebral bone density and fractures in postmenopausal women. Br J Radiol 66:435–440
Fredfeldt KE (1986) Sound velocity in the middle phalanges of the human hand. Acta Radiol Diag 27:723–727
Kaufman JJ, Einhorn TA (1993) Perspectives—ultrasound assessment of bone. J Bone Miner Res 8:517–525
Rico H, Revilla M, Martín-Santos FJ, Cárdenas JL, Fraile E (1994) Comparison between metacarpal bone measurements by computerized radiogrammetry and total body DEXA in normal and osteoporotic women. Clin Rheumatol 13:593–597
Grampp S, Jergas M, Glüer CC, Lang P, Brastow P, Genant HK (1993) Radiological diagnosis of osteoporosis. Current methods and perspectives. Radiol Clin North Am 31:1133–1145
Rico H, Revilla M, Villa LF, Alvarez de Buergo M, Ruiz-Contreras D (1994) Determinants of total and regional bone mineral content and density in postpubertal normal women. Metabolism 43:263–266
Rico H, Revilla M, Hernández ER, Villa LF, Alvarez de Buergo M, Alonso A (1991) Age-related and weight-related changes in total body bone mineral in men. Miner Electrol Metab 17:321–323
Rico H, Revilla M, Cárdenas JL, Villa LF, Fraile E, Martín FJ, Arribas I (1994) Influence of weight and seasonal changes on radiogrammetry and bone densitometry. Calcif Tissue Int 54: 385–388
Martin RB, Burr DB (1989) Structure, function, and adaptation of compact bone. Raven Press, New York
Abdenshein W, Hyatt GW (1970) Ultrasonic and selected physical properties of bone. Clin Orthop 49:294–301
Parfitt AM (1990) Interpretation of bone densitometry measurements: disadvantages of a percentage scale and a discussion of some alternatives. J Bone Miner Res 5:537–539
Krolner B, Nielsen PS (1982) Bone mineral content of the lumbar spine in normal and osteoporotic women: crosssectional and longitudinal studies. Clin Sci 62:329–336
Delmas PD (1990) Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. Endocrinol Metab Clin North Am 19:1–18
Rico H, Revilla M, Iritia M, Arribas I, Villa LF (1991) Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and type III osteogenesis imperfecta. Miner Electrol Metab 17:396–398
Nordin BEC (1978) Diagnostic procedures in disorders of calcium metabolism. Clin Endocrinol 8:55–67
Rico H, Revilla M, Arnanz F, Villa LF, Perera S, Arribas I (1993) Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis. Obstret Gynecol 81:272–275
Rico H, Arnanz F, Revilla M, et al (1993) Total and regional bone mineral content in women treated with GnRH agonists. Calcif Tissue Int 52:354–357
Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD (1982) Vitamin D and bone health in the elderly. Am J Clin Nutr 36:1014–1031
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Revilla, M., de la Sierra, G., Aguado, F. et al. Bone mass in Parkinson's disease: A study with three methods. Calcif Tissue Int 58, 311–315 (1996). https://doi.org/10.1007/BF02509377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02509377